We are live on
!
Find out more
BDS
Banco de Sabadell Portfolio holdings
AUM
$151M
1-Year Est. Return
22.94%
This Fund
S&P 500
This Quarter
Est. Return
+9.07%
1 Year Est. Return
+22.94%
3 Year Est. Return
+65.97%
5 Year Est. Return
+94.89%
10 Year Est. Return
–
AUM
$145M
AUM Growth
+$13M
(+9.9%)
Cap. Flow
+$4.96M
Cap. Flow
% of AUM
3.43%
Top 10 Holdings %
Top 10 Hldgs %
35.5%
Holding
65
New
8
Increased
30
Reduced
19
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blackrock
BLK
|
+$3.19M |
| 2 |
Walmart Inc
WMT
|
+$1.35M |
| 3 |
Meta Platforms (Facebook)
META
|
+$573K |
| 4 |
iShares MSCI Europe Financials ETF
EUFN
|
+$554K |
| 5 |
Mastercard
MA
|
+$378K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$1.2M |
| 2 |
UnitedHealth
UNH
|
+$495K |
| 3 |
AstraZeneca
AZN
|
+$201K |
| 4 |
Costco
COST
|
+$188K |
| 5 |
Accenture
ACN
|
+$185K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 12.96% |
| 4 | Consumer Staples | 10.22% |
| 5 | Consumer Discretionary | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Sanofi
SNY
$105B
| $907K | 0.63% |
18,798
| – | – |
|
52
TE Connectivity
TEL
$60.2B
| $844K | 0.58% |
4,997
| – | – |
|
53
Novartis
NVS
$297B
| $839K | 0.58% |
6,936
+33
| +0.5% | +$3.72K |
|
54
Unilever
UL
$132B
| $754K | 0.52% |
10,958
+29
| +0.3% | +$2.04K |
|
55
British American Tobacco
BTI
$131B
| $743K | 0.51% |
15,678
+1,131
| +8% | +$50.1K |
|
56
nVent Electric
NVT
$24.1B
| $711K | 0.49% |
9,693
| – | – |
|
57
Equinor
EQNR
$91.4B
| $642K | 0.44% |
25,403
| – | – |
|
|
58
AstraZeneca
AZN
$263B
| $418K | 0.29% |
3,009
-1,436
| -32% | -$201K |
|
59
JPMorgan US Quality Factor ETF
JQUA
$8.16B
| $108K | 0.07% |
+1,796
| New | +$103K |
|
60
Capital Group Dividend Value ETF
CGDV
$37.2B
| $47K | 0.03% |
+1,180
| New | +$42.8K |
|
61
Capital Group Growth ETF
CGGR
$23.7B
| $47K | 0.03% |
+1,162
| New | +$42.4K |
|
62
JPMorgan International Research Enhanced Equity ETF
JIRE
$11B
| $47K | 0.03% |
+659
| New | +$43.9K |
|
63
Dimensional Emerging Core Equity Market ETF
DFAE
$9.28B
| $31K | 0.02% |
+1,058
| New | +$28.4K |
|
64
JPMorgan Small & Mid Cap Enhanced Equity ETF
JMEE
$2.87B
| $31K | 0.02% |
+517
| New | +$28.9K |
|
|
65
Target
TGT
$63.7B
| – | – |
-11,528
| Closed | -$1.2M |
|
Similar funds
CCM
WBCM
SHF
CAM
HEC
LM
DIG
FC
Banco de Sabadell's Q2 2025 Portfolio in Review
As of Q2 2025, Banco de Sabadell held 65 positions worth $145M, up 9.9% from $132M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Banco de Sabadell deployed $4.96M of net new capital in Q2 2025, opening 8 new positions and adding to 30 existing holdings. Its largest new stake was Blackrock: 3,372 shares worth $3.54M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was UnitedHealth, an estimated $495K trimmed.
- Banco de Sabadell's largest Q2 2025 buy was Blackrock: 3,372 shares worth $3.54M.
- Banco de Sabadell added most to Meta Platforms (Facebook) in Q2 2025, an estimated $573K increase.
- Banco de Sabadell's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $495K.
- Banco de Sabadell fully exited Target in Q2 2025, selling an estimated $1.2M.
- Banco de Sabadell's ten largest holdings make up 35% of its $145M portfolio in Q2 2025.
- Banco de Sabadell opened 8 new positions and closed 1 in Q2 2025.
- Banco de Sabadell's portfolio value rose 9.9% quarter-over-quarter to $145M.
Based on Banco de Sabadell's 13F filing for Q2 2025, filed 13 Aug 2025.